High Tumor Mutation Burden and Other Immunotherapy Response Predictors in Breast Cancers: Associations and Therapeutic Opportunities

被引：0
|
作者：
Ioannis A. Voutsadakis
机构：
[1] Algoma District Cancer Program,Section of Internal Medicine, Division of Clinical Sciences
[2] Sault Area Hospital,undefined
[3] Northern Ontario School of Medicine,undefined
来源：
Targeted Oncology | 2020年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：127 / 138
页数：11
相关论文
共 50 条
  • [1] High Tumor Mutation Burden and Other Immunotherapy Response Predictors in Breast Cancers: Associations and Therapeutic Opportunities
    Voutsadakis, Ioannis A.
    TARGETED ONCOLOGY, 2020, 15 (01) : 127 - 138
  • [2] The Landscape of Chromosome Instability in Breast Cancers and Associations with the Tumor Mutation Burden: An Analysis of Data from TCGA
    Voutsadakis, Ioannis A.
    CANCER INVESTIGATION, 2021, 39 (01) : 25 - 38
  • [3] Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy
    Wang, Peipei
    Chen, Yueyun
    Wang, Chun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Correlation between tumor mutation burden and response to immunotherapy.
    Bonta, Ioana
    Isac, John Florin
    Meiri, Eyal
    Bonta, Dacian
    Rich, Patricia
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
    Mary A. Wood
    Benjamin R. Weeder
    Julianne K. David
    Abhinav Nellore
    Reid F. Thompson
    Genome Medicine, 12
  • [6] Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
    Wood, Mary A.
    Weeder, Benjamin R.
    David, Julianne K.
    Nellore, Abhinav
    Thompson, Reid F.
    GENOME MEDICINE, 2020, 12 (01)
  • [7] Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
    Goodman, Aaron M.
    Kato, Shumei
    Bazhenova, Lyudmila
    Patel, Sandip P.
    Frampton, Garrett M.
    Miller, Vincent
    Stephens, Philip J.
    Daniels, Gregory A.
    Kurzrock, Razelle
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (11) : 2598 - 2608
  • [8] Hot or Not: Tumor Mutational Burden (TMB) as a Biomarker of Immunotherapy Response in Genitourinary Cancers
    Halbert, Brian
    Einstein, David J.
    UROLOGY, 2021, 147 : 119 - 126
  • [9] BLM mutation is associated with increased tumor mutation burden and improved survival after immunotherapy across multiple cancers
    Shi, Huiping
    Gao, Liang
    Yin, Hong
    Jiang, Min
    CANCER MEDICINE, 2024, 13 (01):
  • [10] High Tumor Mutation Burden in Small-Cell Lung Cancer May Predict Improved Immunotherapy Response
    不详
    ONCOLOGY-NEW YORK, 2017, 31 (11): : 836 - +
12345